{"chief_complaint_en": ["Shortness of Breath"], "content": {"about": {"evidence_based_medicine_en": "", "formula_en": "<p>Addition of assigned points, as above.</p>", "more_info_en": "<p><strong>Score interpretation:</strong></p> <div class='table-responsive'> <table class='table table-bordered table-hover'> <tbody> <tr> <th>Total Risk Score</th> <th>Expected 1-year probability of death</th> </tr> <tr> <td>0\u20134</td> <td>&lt;2%</td> </tr> <tr> <td>8\u201314</td> <td>2-5%</td> </tr> <tr> <td>16\u201321</td> <td>5\u201310%</td> </tr> <tr> <td>22\u201329</td> <td>10\u201320%</td> </tr> <tr> <td>30\u201333</td> <td>20\u201330%</td> </tr> <tr> <td>34\u201337</td> <td>30\u201340%</td> </tr> <tr> <td>38\u201340</td> <td>40\u201350%</td> </tr> <tr> <td>41\u201343</td> <td>50\u201360%</td> </tr> <tr> <td>44\u201345</td> <td>60\u201370%</td> </tr> <tr> <td>47\u201349</td> <td>70\u201380%</td> </tr> <tr> <td>&gt;50</td> <td>&gt;80%</td> </tr> </tbody> </table> </div>", "references_list": {"Original/Primary Reference": [{"href": "http://www.ncbi.nlm.nih.gov/pubmed/21616999", "text": "du Bois RM, Weycker D, Albera C, Bradford WZ, Costabel U, Kartashov A, et al. Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med.2011;184:459\u201366. doi: 10.1164/rccm.201011-1790OC."}], "Validation": [{"href": "http://www.ncbi.nlm.nih.gov/pubmed/21940789", "text": "du Bois RM, et. al. Forced Vital Capacity in Patients with Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine 2011 184:12, 1382-1389."}], "Other References": [{"href": "http://err.ersjournals.com/content/errev/23/132/220.full.pdf", "text": "Kolb M, Collard HR. Staging of idiopathic pulmonary fibrosis: past, present and future Eur Respir Rev 2014; 23: 220\u2013224."}, {"href": "http://thorax.bmj.com/content/67/Suppl_2/A120.1", "text": "Wilkie MEM, Chalmers JD, Smith RP, Schembri S. Asthma outcomes: P134\u2005Comparison of Two Prognostic Tools For Identifying High Risk Patients with Idiopathic Pulmonary Fibrosis. Thorax 2012;67:Suppl 2 A120 doi:10.1136/thoraxjnl-2012-202678.417"}]}}, "contributor": {"expert_name": []}, "creator": [{"name": "Dr. Roland du Bois", "qa_en": "", "creator_info": {"about_en": "<p>Roland M. Dubois, MD, is a professor of respiratory medicine and senior research investigator at Imperial College in London. Previously, he was a professor at National Jewish Health in Denver and Consultant Physician at the Royal Brompton Hospital. Dr. du Bois advises on studies of innovative therapy for idiopathic pulmonary fibrosis and conducts research on genetics, pathogenesis and treatment of interstitial lung diseases.</p>", "photo_en": "https://cdn-web-img.mdcalc.com/people/dr-roland-du-bois.jpeg", "pubmedLink": "http://www.ncbi.nlm.nih.gov/pubmed/?term=du+Bois+RM%5BAuthor%5D"}}], "how_to_use": {"pearls_pitfalls_en": "<p>The du Bois Score is more specific, but less sensitive, compared to the <calculator id='2157'>GAP Index</calculator> for predicting mortality.</p>", "use_case_en": "<p>1-year prognostication of IPF patients needing lung transplantation.</p>", "why_use_en": "<p>Simple, internally validated tool for determining IPF prognosis and guiding clinical management using longitudinal data.</p>"}, "next_steps": {"advice_en": "<p>Higher scores correspond to a greater need for transplantation and other treatments.</p>", "critical_actions_en": "", "management_en": ""}}, "disease_en": ["Idiopathic Pulmonary Fibrosis"], "favorite_id": 2156, "full_title_en": "du Bois Score for Idiopathic Pulmonary Fibrosis (IPF) Mortality", "input_schema": [{"label_en": "Age", "options": [{"label": "<60 years", "value": 0}, {"label": "60-69 years", "value": 4}, {"label": "\u226570 years", "value": 8}], "show_points": true, "type": "radio", "name": "age", "optional": false}, {"default": 0, "label_en": "Respiratory hospitalization in past 6 months", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 14}], "show_points": true, "type": "toggle", "name": "hosp", "optional": false}, {"default": 0, "label_en": "Predicted baseline forced vital capacity (FVC)", "options": [{"label": "\u226580%", "value": 0}, {"label": "66-79%", "value": 8}, {"label": "51-65%", "value": 13}, {"label": "\u226450%", "value": 18}], "show_points": true, "type": "radio", "name": "fvc", "optional": false}, {"default": 2, "label_en": "24-Week change in predicted FVC", "options": [{"label": "\u2264-10%", "value": 21}, {"label": "-5% - -9.9%", "value": 10}, {"label": "\u2265-4.9%", "value": 0}], "show_points": true, "type": "radio", "name": "fvc24", "optional": false}], "instructions_en": "", "medium_description_en": "Determines 1-year mortality in IPF patients using PFT and clinical indicators.", "purpose_en": ["Prognosis"], "search_abbreviation_en": ["dubois", "mortality", "ipf"], "seo": {"meta_description_en": "du Bois Score for Idiopathic Pulmonary Fibrosis (IPF) Mortality determines 1-year mortality in IPF patients using PFT and clinical indicators.", "keywords_en": "dubois score, du bois score, ipf mortality, ipf du bois, ipf du bois score, idiopathic pulmonary fibrosis mortality, idiopathic pulmonary fibrosis score, ipf score"}, "short_description_en": "Mortality risk in IPF.", "short_title_en": "du Bois Score for IPF", "slug": "du-bois-score-idiopathic-pulmonary-fibrosis-ipf-mortality", "specialty_en": ["Critical Care", "Hospitalist Medicine", "Internal Medicine", "Palliative Care/Hospice", "Pulmonology"], "system_en": ["Respiratory"], "calc_type": "calculator", "dosing": false, "before_use": "", "md5": "4b4beca905cdabf71aa0704c6d005e40", "related_calcs": [{"calcId": 2157, "short_title_en": "GAP Index for IPF", "slug": "gap-index-idiopathic-pulmonary-fibrosis-ipf-mortality"}, {"calcId": 10371, "short_title_en": "CIRC", "slug": "covid-19-inpatient-risk-calculator-circ"}, {"calcId": 10338, "short_title_en": "4C Mortality Score for COVID-19", "slug": "4c-mortality-score-covid-19"}]}